Israel Japan | Business Guide | 2018

Life Science Industry > MedTech & Pharma > 049 B y the end of the 1990s, Israel was home to more than 200 Life Science companies.With steady growth over the last decade,Israel has introduced creativity and innovation into the field;today there are over 1200 active Life Science companies. In a relatively short period of time, an impressive 34% of these companies are already generating revenues.Israel’s entrepreneurial ecosystem creates opportunities for start-ups to become advanced, commercially viable and promising businesses.Between 2005 and 2014,the number of Life Science companies in Israel grew significantly.Most Life Science companies (66%) were founded during that decade.Approximately 36% of the companies founded between 2011 and 2014 develop digital healthcare products. More than 500 exporters The Largest Sector in the Life Science Industry is Medical Devices and HealthCare IT Technologies (more than 60% of companies).In the Medical Devices arena,Israeli scientists and engineers have integrated advanced technologies in electronics, communications and electro- optics to develop world-class innovations in Digital Imaging,Medical Lasers,Telemedicine, Early Diagnostic, Smart Surgical Equipment and more. More than 500 medical device exporters engaged in a variety of medical applications such as Cardiovascular and Peripheral Vascular,Neurology and Degenerative Diseases, Emergency Medicine, Intensive Care and Rehabilitation, Respiratory and Airway Management, Oncology, Women’s Health, Orthopedics and Sports Medicine, Gastrointestinal Treatment, Infection Control, Ophthalmology, Pain and Wound Management,Oral and Dental and Dermatology and Aesthetics. Japan: Looking for unique and sophisticated products After the US, Japan has the second-largest healthcare, pharmaceutical and medical devices markets in the world.Total medical Innovative Medical Technologies that Answer Today’s Healthcare Challenges On one hand, over 1,200 Life Science companies are active today in Israel. On the other hand, the Japanese Government has implemented widespread changes in health-related policies, regulations and laws. Now is the best time for new business opportunities expenditure is over GBP 250 billion a year and the Japanese pharmaceutical market is larger than both France and Germany's combined. For the healthcaremarket,unique,sophisticated, and highly technical products are sought to assist elderly people - ranging from healthy elderly people to those with disabilities. For the Medical Devices market, opportunities exist with advanced and innovative products for exports of finished products,joint R&D and technology licensing.In pharmaceuticals,the demand for joint development,outsourcing of R&D, clinical trials and regulatory affairs continues to increase.  The Japanese Government has implemented widespread changes in health-related policies, regulations,and laws.National Strategic Special Zones,which are selected regions that offer relaxed regulations and tax benefits, are encouraging creation of innovative drugs and Medical Devices.While Japanese companies and universities seek foreign partners, the government is actively promoting foreign investment and other business from non- Japanese companies. Now is the best time for increased cooperation between Japanese and Israeli companies. Sources: Israel Export Institute, Invest in Israel, Export to Japan, Invest in Japan 1995: Agreement between the Government of Japan and the Government of Israel on Cooperation in Science and Technology. The beginning of 90’s: Orbotech Company expands its operations to Japan. Historical Moments